Baeyens and colleagues [138] further demonstrated that breast cancer patients with BRCA1 or BRCA2 mutations showed higher micronucleus frequencies than the controls, but interestingly, there was no difference compared with breast cancer patients without BRCA1 or BRCA2 mutations. The gene discussed is BRCA2; the disease is breast carcinoma.